Guess its good to try work out what the guidance may be next?...

Guess its good to try work out what the guidance may be next?

Ive done what I can to extrapolate figures and then use off the cuff theory based on nothing more than dartboards and smelling salts, but here are my own BAL figures guesstimates.

Revenue $220m (not going with the $240m, used July-Nov figures)
Gross Profit $99m (was 45%, guidance said GP margins increasing, Ill use 45%)
Direct Costs $30m (was 11% of revenue, now 14% to allow for inventory loss)
employee $12m (sameish)
marketing $15m (55% increase, its needed IMO)
Admin $12m (sameish)
EBIT $30m (around 14%)
NPAT $21m
** Cash on hand $30m

At 20 x NPAT + cash I put them circa $450m conservative valuation.
Say about $5 share.

***I do see decent improvement from here however with the extra $8m spend on marketing YOY and lower cost output with inventory write off being a once off (hopefully), along with new Chinese regs to reduce product from 2000 to 250.

Anyway happy for anyone to rip me a new one, discuss, debunk, agree, whatever you like.